What Worked What Didn't: Earnings Season Insights
This earnings season produced a mix of wins and misses. We break down what worked what didn't, with actionable tips y...
When rebalancing, certain events can trigger taxes. This introduction explains common tax events tied to rebalancing and how to recognize potential tax impacts upfront.
13,064 articlesThis earnings season produced a mix of wins and misses. We break down what worked what didn't, with actionable tips y...
In a pivotal speech, the former chair jerome powell sends a clear message about inflation and political pressure. Inv...
Roku stock jumped Friday on chatter of a potential sale, but the real action could come from a June 22 event investor...
SpaceX has joined the NASDAQ 100, but veteran skepticism remains. Famed investor jeremy gratham says today’s hype cou...
Investors started July with fresh gains as major indices rose and a marquee IPO sparked optimism. Learn what drove th...
When a top executive sells a large block of stock, investors want to know whether it signals trouble or simply person...
In early 2026, retirees are increasingly adopting a low-volatility ETF to stabilize portfolios amid ongoing market vo...
When an executive at Century Aluminum sells millions in stock, investors take notice. This article breaks down what t...
A single Tuesday remark from a prominent political figure can ripple through the markets. This article explains what ...
The weight loss drug space has become a focus for growth-minded investors. This guide weighs Eli Lilly's proven progr...
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
A biotech insider sale can spark questions about company momentum. This article digs into the Stoke Therapeutics CMO ...